Di Nuzzo Private Wealth, Inc. Exact Sciences Corp Transaction History
Di Nuzzo Private Wealth, Inc.
- $618 Million
- Q4 2024
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 14 shares of EXAS stock, worth $619. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14
Previous 14
-0.0%
Holding current value
$619
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding EXAS
# of Institutions
667Shares Held
152MCall Options Held
4.25MPut Options Held
1.89M-
Capital World Investors Los Angeles, CA17.5MShares$776 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$753 Million0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$534 Million0.01% of portfolio
-
State Street Corp Boston, MA6.23MShares$276 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.76MShares$255 Million0.04% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $7.83B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...